Primary Sjogren's syndrome associated with inappropriate antidiuretic hormone secretion : a case report by De Villiers, W. J. S. & Klemp, P.
12. Jessop S, Myers OL. Systemic lupus erythematosus in Cape Town. S Afr
MedJ 1973; 47: 222-225.
13. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus.
Semin Arrhn'/is Rheum 1973; 3: 1-9.
14. Fessel1- Systemic lupus erythematosus in the communiry. Arch Intem Med
1974; 143: 1027-1035.
15. Siegel M, Holley HL, Lee SL. Epidemiologic studies on systemic lupus
erythematosus: comparative data for New York City and Jefferson County,
Alabama, 1956-1965. Ar/hri/isRheum 1970; 13:802-811.
16. Otieno LS, Wairagu SG, Waweru HW. Systemic lupus erythematosus at
SAMJ VOL. 79 19 JAN 1991 103
Kenyana National Hospital, 1972-1984. East Afr MedJ 1985; 62: 391-396.
17. Bahemuka M, Bhau KM. Transient retinopathy in uncomplicated case of
systelDlc lupus erythematosus. East Afr MedJ 1980; 57: 500-504.
18. I?ernen fP'. ~onnanf CD, MODDier A, Ducloux M. Lupus erythemateux
31gu disselDlDe chez I Mncain de race noire. Bull Soc Med Afr Noire Long Fr
1976; 21: 65-70.
19". Ransome OJ, Thomson PD. Systemic lupus erythematosus with nephritis in
children: a repon of 6 cases. S Afr MedJ 1986; 69: 629-633.
20. Walpon MJ, Black CM, Batchelor JR. The immunogenetics of SLE. Clin
Rheum Dis 1982; 8: 3-21.
Primary Sjogren's syndrome associated with
inappropriate antidiuretic hormone secretion
A case report
W. J. S. DE VILLlERS, P. KLEMP
Summary Case report
A patient in whom primary Sjogren's syndrome and inappro-
priate antiduretic hormone secretion were associated is
reported. This is the first report of such an association. The
possible pathophysiological mechanisms are discussed and
vasculitis proposed as the L:nderlying pathogenetic
mechanism.
SAtf Med J 1991; 79: 103-104.
Sjogren's syndrome is an auto-immune disorder with a pre-
dilection for multisystem involvement.! Xerophthalmia and
xerostomia from a destructive mononuclear infiltration of the
lacrimal and salivary glands are characteristic. Central nervous
system (CNS) involvement includes recurrent aseptic meningo-
encephalitis, necrotisin~ spinal arteritis and unifocal and multi-
focal cerebral disease. ,3 Inappropriate secretion of arginine
vasopressin (SIADH) is a form of hyponatraemia in which
there is an elevated level of antidiuretic hormone (ADH) in-
appropriate to any physiological stimuli present that normally
affect ADH secretion.4 Among the causes are malignant'
tumours, chest infections and CNS disturbances.4
A patient in whom primary Sjogren's syndrome and inappro-
priate ADH secretion were associated is reported. This is the
first report of such an association. The possible pathophysio-
logical mechanisms are discussed.
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A 56-year-old woman presented to hospital with a generalised
convulsion. She was not hypovolaemic and, apart from a
decreased level of consciousness, the neurological system was
normal.
The serum sodium level was III mmol/I (normal 133 - 146
mmol/l), chloride 74 mmol/I (normal 96 - 106 mmol/l), urea
2,1 mmol/l (normal 3,3 - 6,5 mmol/l), uric acid 0,18 mmol/I
(normal 0,20 - 0,45 mmol/l) and osmolaliry 237 mmol/kg H20
(normal 275 - 290 mmol/kg H 20). Serum potassium, glucose
and creatinine values were normal. Urinalysis revealed a normal
sediment, no proteinuria or glycosuria and a sodium content of
63 mmol/I, potassium 123 mmol/l, chloride 94 mmol/l and
osmolaliry 488 mmol/kg H20 (normal 50 - 1400 mmol/kg
H20). The full blood count was normal, the erythrocyte
sedimentation rate was 100 mm/1st h (Westergren) and the
C-reactive protein 49 mgll (normal < 10 mgll).
Blood culture and toxicology screening for phenothiazines,
ethanol, paracetamol, barbiturates and benzodiazepines were
negative. An ECG, chest radiography, blood gas analysis,
thyroid function tests and the cortisol level were norm~ and
screening for porphyrin in urine and stool was negative.
Computed tomography of the brain and cerebrospinal fluid
examination were non-contributory, while electro-encephalo-
graphy showed nonspecific diffuse changes compatible with a
metabolic encephalopathy.
SIADH was diagnosed and fluid intake restricted to 500
ml/24 h. In addition, 200 ml of 5% saline was administered
twice 8-hourly. The serum sodium level rose to 126 mmol/l
within 24 hours and the patient became fully conscious.
Serum and urine electrolyte values and osmolaliry returned to
normal and remained so.
Further enquiry revealed a 3-year history of dry eyes and
mouth and swelling of the left parotid gland. There was no
history of skin rashes, Raynaud's phenomenon, oral or genital
ulcers, photosensitiviry, serositis or musculoskeletal symptoms.
The patient denied any drug intake. No salivary gland enlarge-
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ment or lymphadenopathy were present but an absence of
pooling of saliva in the floor of the mouth was noted. Slit-
lamp examination of the eyes showed a diminished tear ftlm
and punctate areas of epithelial loss were demonstrated with
1% rose bengal drops. Liver function tests, serum creatine
kinase, aldolase, calcium, magnesium, phosphate and comple-
ment levels was normal. Cryog~obulins were negative and a
hyperglobulinaemia of 42 g/l with increased IgA and IgG
levels were demonstrated. .
The rheumatoid factor was pOsitive on three and the Rose-
Waaler test on two occasions (titres of 1:80 and 1:20). Anti-
nuclear antibodies ranged from 1:10 to 1:1280 (speckled
pattern) and anti-Sm and anti-RNP antibodies were positive
on three occasions. Anti-double-stranded DNA, anti-Ro (SAA)
and anti-La (SSB) antibodies were persistently negative. A
labial salivary gland biopsy revealed focal mononuclear cell
inltltration. The patient was treated with artificial tears and
has remained well for 26 months.
Discussion
SIADH was first described by Schwartz er a1. 5 Diagnostic
criteria for this syndrome have subsequently evolved and
include: (I) hypotonic hyponatraemia; (i/) urine osmolality
higher than would be anticipated for the degree of hyponatrae-
mia; (iil) normal renal, adrenal and pituitary function; (iv)
excretion of appreciable quantities of sodium in the euvolaemic
patient; (v) absence of hypovolaemia or dehydration; (VI)
absence of a condition associated with generalised oedema or
ascites; and (viI) correction of both the hypotonic hyponatrae-
mia and natriuresis by severe fluid restriction.4 Our patient
fulItlled all these criteria and was on no medication, such as
diuretics and non-steroidal anti-inflammatory agents, which
can cause a SIADH-like picrure.6 The hypo-uraemia and
hypo-uricaemia present in our patient have been well described
in SIADHY
In a sm~ number of patients with SIADH no cause can be
identified, but Martinez-Maldonad09 advises caution in diag-
nosing 'idiopathic' SIADH, since the syndrome might precede
overt disease, specifically cancer, by months or years.
The diagnosis of primary Sjogren's syndrome (sicca syn-
drome) was made by the triad of keratoconjunctivitis sicca,
xerostomia and mononuclear cell inltltration in a labial salivary
gland biopsy, and the clinical and serological exclusion of
other connective tissue disease. lO•lI When diminished tear
secretion and punctate keratitis coexist, keratoconjunctivitis
sicca is considered present. No entirely satisfactory clinical or
laboratory tests are as yet available for the diagnosis of the oral
component of Sjogren's syndrome. The most reliable signs are
probably the absence of pooling of saliva in the floor of the
mouth and unilateral, episodic parotid gland enlargement,
both of which were present in our patient. lO Focal lymphocytic
inltltrates in minor salivary glands are' seen in over 70% of
patients with Sjogren's syndrome. lO
A computer-assisted search of'medical publications revealed
no previous report of an association between primary SjOgren's
syndrome and SIADH. This association could be entirely
fortuitous. The rarity of idiopathic SIADH and the patient's
well-being 26 months after diagnosis suggest that there is a
true association between the two conditions.
Possible pathogenetic mechanisms to explain CNS mani-
festations of Sjogren's syndrome include vasculitis, direct
mononuclear cell inltltration of CNS tissue, antineuronal auto-
antibodies and cerebral vasospasm.2 An association between
peripheral vasculitis, CNS involvement and anti-Ro (SSA)
antibodies has been described in primary Sjogren's syndromeY
Vasculitis probably accounts for a significant proportion of
CNS complications in Sjogren's syndrome. lO The diversity of
CNS manifestations in Sjogren's syndrome is comparable to
that of systemic lupus erythematosus and it is conceivable that
the underlying pathogenetic; mechanisms, including vasculitis,
may be similar..12 Systemic lupus erythematosus vasculitis has
previously been reported as a cause of SIADH, with immune-
mediated inflammation postulated to have caused release of.
ADH from the neighbouring neurohypophysis.9
In similar fashion, we propose a direct association between
primary Sjogren's syndrome and the subsequent development
of SIADH in our patient, with vasculitis as the possible
underlying pathogenetic mechanism.
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